BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tian T, Fu X, Lu J, Ruan Z, Nan K, Yao Y, Yang Y. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway. J Biochem Mol Toxicol. 2018;32:e22167. [PMID: 29968951 DOI: 10.1002/jbt.22167] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Cai Z, Liang J, Chai E, Lu A, Shang Y. CircCPA4 Promotes the Malignant Phenotypes in Glioma via miR-760/MEF2D Axis. Neurochem Res 2020;45:2903-13. [DOI: 10.1007/s11064-020-03139-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang M, Yu F, Chen X, Li P, Wang K. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma. Mol Ther Nucleic Acids 2020;21:13-27. [PMID: 32505000 DOI: 10.1016/j.omtn.2020.05.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Yin L, Sun T, Liu R. NACC-1 regulates hepatocellular carcinoma cell malignancy and is targeted by miR-760. Acta Biochim Biophys Sin (Shanghai) 2020;52:302-9. [PMID: 32091103 DOI: 10.1093/abbs/gmz167] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wang Q, Yan C, Zhang P, Li G, Zhu R, Wang H, Wu L, Xu G. Microarray Identifies a Key Carcinogenic Circular RNA 0008594 That Is Related to Non-Small-Cell Lung Cancer Development and Lymph Node Metastasis and Promotes NSCLC Progression by Regulating the miR-760-Mediated PI3K/AKT and MEK/ERK Pathways. Front Oncol 2021;11:757541. [PMID: 34858831 DOI: 10.3389/fonc.2021.757541] [Reference Citation Analysis]
5 Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y, Liu Z, Xu Q, Liu S, Xiao D, Tao Y. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer 2020;19:47. [PMID: 32122355 DOI: 10.1186/s12943-020-01171-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 14.5] [Reference Citation Analysis]
6 Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli MP, Talora C, Screpanti I, Palermo R. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives. Cancers (Basel) 2021;13:5106. [PMID: 34680255 DOI: 10.3390/cancers13205106] [Reference Citation Analysis]
7 Li LL, Wei L, Zhang N, Wei WY, Hu C, Deng W, Tang QZ. Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway. Biomed Res Int 2020;2020:8593617. [PMID: 32596387 DOI: 10.1155/2020/8593617] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Liu W, Li Y, Feng S, Guan Y, Cao Y. MicroRNA-760 inhibits cell viability and migration through down-regulating BST2 in gastric cancer. J Biochem 2020;168:159-70. [PMID: 32167539 DOI: 10.1093/jb/mvaa031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wang L, Luo Y, Zheng Y, Zheng L, Lin W, Chen Z, Wu S, Chen J, Xie Y. Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma. Biol Direct 2020;15:11. [PMID: 32620145 DOI: 10.1186/s13062-020-00265-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Liang Y, Liang Q, Qiao L, Xiao F. MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma. Front Oncol 2020;10:920. [PMID: 32695666 DOI: 10.3389/fonc.2020.00920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
11 Guo J, Li P, Liu X, Li Y. NOTCH signaling pathway and non-coding RNAs in cancer. Pathol Res Pract 2019;215:152620. [PMID: 31564572 DOI: 10.1016/j.prp.2019.152620] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
12 Wei L, Wang X, Lv L, Liu J, Xing H, Song Y, Xie M, Lei T, Zhang N, Yang M. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol Cancer. 2019;18:147. [PMID: 31651347 DOI: 10.1186/s12943-019-1086-z] [Cited by in Crossref: 97] [Cited by in F6Publishing: 107] [Article Influence: 32.3] [Reference Citation Analysis]
13 Fang N, Li P. O-linked N-acetylglucosaminyltransferase OGT inhibits diabetic nephropathy by stabilizing histone methyltransferases EZH2 via the HES1/PTEN axis. Life Sci 2021;274:119226. [PMID: 33609540 DOI: 10.1016/j.lfs.2021.119226] [Reference Citation Analysis]
14 Taheri M, Mahmud Hussen B, Tondro Anamag F, Shoorei H, Dinger ME, Ghafouri-Fard S. The role of miRNAs and lncRNAs in conferring resistance to doxorubicin. J Drug Target 2021;:1-21. [PMID: 33788650 DOI: 10.1080/1061186X.2021.1909052] [Reference Citation Analysis]
15 Wang Y, Wang H, Zhang J, Chu Z, Liu P, Zhang X, Li C, Gu X. Circ_0007031 Serves as a Sponge of miR-760 to Regulate the Growth and Chemoradiotherapy Resistance of Colorectal Cancer via Regulating DCP1A. Cancer Manag Res 2020;12:8465-79. [PMID: 32982440 DOI: 10.2147/CMAR.S254815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Zhang X, Ma L, Zhai L, Chen D, Li Y, Shang Z, Zhang Z, Gao Y, Yang W, Li Y, Pan Y. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Int J Med Sci 2021;18:984-99. [PMID: 33456356 DOI: 10.7150/ijms.49126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Wang W, Sun R, Zeng L, Chen Y, Zhang N, Cao S, Deng S, Meng X, Yang S. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Life Sci 2021;276:119439. [PMID: 33785338 DOI: 10.1016/j.lfs.2021.119439] [Reference Citation Analysis]
18 Yang D, Hu Z, Xu J, Tang Y, Wang Y, Cai Q, Zhu Z. MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin β1. Biosci Rep 2019;39:BSR20192358. [PMID: 31693728 DOI: 10.1042/BSR20192358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Sritharan S, Sivalingam N. A comprehensive review on time-tested anticancer drug doxorubicin. Life Sci 2021;278:119527. [PMID: 33887349 DOI: 10.1016/j.lfs.2021.119527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Yuan XW, Yan TQ, Tong H. Effect of miR-515-5p on Proliferation and Drug Sensitivity of Retinoblastoma Cells. Cancer Manag Res 2020;12:12087-98. [PMID: 33262657 DOI: 10.2147/CMAR.S271165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
21 Yang X, Zhang C, Tie H, Luo J, Wang Y, Wu Q. miR-760 exerts an antioncogenic effect in esophageal squamous cell carcinoma by negatively driving fat metabolism via targeting c-Myc. J Cell Biochem 2020;121:2950-61. [PMID: 31709636 DOI: 10.1002/jcb.29540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Liu Y, Fang B, Feng X, Jiang Y, Zeng Y, Jiang J. Mechanism of IDH1-R132H mutation in T cell acute lymphoblastic leukemia mouse model via the Notch1 pathway. Tissue Cell 2021;74:101674. [PMID: 34814054 DOI: 10.1016/j.tice.2021.101674] [Reference Citation Analysis]
23 Ge L, Wang Y, Duan QH, Liu SS, Liu GJ. MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription. World J Gastroenterol 2019; 25(45): 6619-6633 [PMID: 31832002 DOI: 10.3748/wjg.v25.i45.6619] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Cen L, Liu R, Liu W, Li Q, Cui H. Competing Endogenous RNA Networks in Glioma. Front Genet 2021;12:675498. [PMID: 33995499 DOI: 10.3389/fgene.2021.675498] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Manvati MKS, Khan J, Verma N, Dhar PK. Association of miR-760 with cancer: An overview. Gene 2020;747:144648. [PMID: 32251703 DOI: 10.1016/j.gene.2020.144648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]